Biotech Series B Investors & VC Firms
900 firms in this list, with a median first check of $550K. 188 of them lead rounds. Generated from verified public data and updated continuously.
YFY Biotech Management Company
TaipeiSeed–Series B
1 person
Biomark Capital
GreenwichSeries A–Late Stage$5M – $10M
4 people
SEB Greentech Venture Capital
StockholmSeed–Growth$1.1M – $4.3M
4 people
Thuja Capital
UtrechtSeed–Series B
7 people
Hefei High-tech VC
HefeiSeed–Series C
New Leaf Venture Partners
New YorkSeed–Late Stage
5 people
E15
Hong KongPre-Seed–Late Stage
Egora Holding
MartinsriedPre-Seed–Late Stage$5.4M
GERBER-RAUTH
MilanPre-Seed–Late Stage
Anais Ventures
LancySeries A–Series C
3 people
Boxer Capital, LLC
San DiegoSeed–Late Stage
JAFCO Group
TokyoPre-Seed–Late Stage$1.9M – $198M
Stonebridge Ventures
SeoulSeed–Late Stage$743K – $33M
3 people
CDF-Capital
ShenzhenSeed–Late Stage
City Side Ventures LLC
BirminghamSeed–Late Stage$150K – $10M
3 people
Comway Capital Ltd.
ShanghaiSeed–Series B
Dalton Venture
ShanghaiSeed–Series B
Ela Capital
TorontoPre-Seed–Growth
Hiroshima Innovation Network
HiroshimaPre-Seed–Growth
IDB Lab
Washington, D.C.Pre-Seed–Series B
Ikarian Capital
DallasPre-Seed–Late Stage
Impulsora de Innovacion Mexico
Mexico CityPre-Seed–Growth$1M
Laval Innov
LavalPre-Seed–Late Stage
MagogTechnopole
MagogPre-Seed–Late Stage
Related lists
Series B Investors & VC Firms (4094)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)Series B Investors & VC Firms in United States (1625)Biotech Series A Investors & VC Firms (1596)SaaS Series B Investors & VC Firms (1317)Series B Investors & VC Firms in Global (1265)Enterprise Software Series B Investors & VC Firms (1242)Healthtech Series B Investors & VC Firms (1216)Fintech Series B Investors & VC Firms (1141)
Data sourced from public filings and firms' own websites — see our methodology.


